The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Apomorphine Hydrochloride Injection Market Research Report 2024
Synopsis
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride Injection market was valued at US$ 249 million in 2023 and is anticipated to reach US$ 327.3 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride Injection.
Report Scope
The Apomorphine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Segment by Type
Pen Injectors
Infusion Pumps
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride Injection market was valued at US$ 249 million in 2023 and is anticipated to reach US$ 327.3 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride Injection.
Report Scope
The Apomorphine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Segment by Type
Pen Injectors
Infusion Pumps
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Apomorphine Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Apomorphine Hydrochloride Injection
1.2 Apomorphine Hydrochloride Injection Segment by Type
1.2.1 Global Apomorphine Hydrochloride Injection Market Value Comparison by Type (2024-2030)
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Apomorphine Hydrochloride Injection Segment by Application
1.3.1 Global Apomorphine Hydrochloride Injection Market Value by Application: (2024-2030)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Injection Revenue 2019-2030
1.4.2 Global Apomorphine Hydrochloride Injection Sales 2019-2030
1.4.3 Global Apomorphine Hydrochloride Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Apomorphine Hydrochloride Injection Average Price by Manufacturers (2019-2024)
2.4 Global Apomorphine Hydrochloride Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Type & Application
2.7 Apomorphine Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Apomorphine Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apomorphine Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Apomorphine Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Apomorphine Hydrochloride Injection Global Apomorphine Hydrochloride Injection Sales by Region: 2019-2030
3.2.1 Global Apomorphine Hydrochloride Injection Sales by Region: 2019-2024
3.2.2 Global Apomorphine Hydrochloride Injection Sales by Region: 2025-2030
3.3 Global Apomorphine Hydrochloride Injection Global Apomorphine Hydrochloride Injection Revenue by Region: 2019-2030
3.3.1 Global Apomorphine Hydrochloride Injection Revenue by Region: 2019-2024
3.3.2 Global Apomorphine Hydrochloride Injection Revenue by Region: 2025-2030
3.4 North America Apomorphine Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
3.4.3 North America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
3.5.3 Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
3.7.3 Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
4.1.1 Global Apomorphine Hydrochloride Injection Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Injection Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
4.2.1 Global Apomorphine Hydrochloride Injection Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Injection Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
5.1.1 Global Apomorphine Hydrochloride Injection Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Injection Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
5.2.1 Global Apomorphine Hydrochloride Injection Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Injection Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Corporation Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Corporation Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Corporation Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ever Pharma Apomorphine Hydrochloride Injection Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Injection Industry Chain Analysis
7.2 Apomorphine Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Injection Production Mode & Process
7.4 Apomorphine Hydrochloride Injection Sales and Marketing
7.4.1 Apomorphine Hydrochloride Injection Sales Channels
7.4.2 Apomorphine Hydrochloride Injection Distributors
7.5 Apomorphine Hydrochloride Injection Customers
8 Apomorphine Hydrochloride Injection Market Dynamics
8.1 Apomorphine Hydrochloride Injection Industry Trends
8.2 Apomorphine Hydrochloride Injection Market Drivers
8.3 Apomorphine Hydrochloride Injection Market Challenges
8.4 Apomorphine Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
